Melinta是Cempra制药公司的继承实体。Cempra制药公司位于北卡罗来纳州教堂山市,于2005年11月18日成立,是一家开发抗细菌...查看全文
用户48783635432019-04-10 11:18
【4月9日医药股盘点】$Histogenics(HSGX)$$PhaseBio制药(PHAS)$ $Melinta Therapeutics(MLNT)$ 细胞疗法公司Histogenics同制药公司Ocugen合并,上涨56%;制药公司PhaseBio Pharmaceuticals上涨17.15%;抗生素开发公司Melinta Therapeutics上涨15.15%等。查看全文网页链接查看全文
$Melinta Therapeutics, Inc.(MLNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-11-29 AccNo: 0001193125-17-355847 Size: 174 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-11-29 AccNo: 0001193125-17-355854 Size: 57 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-11-29 AccNo: 0001193125-17-355852 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-11-29 AccNo: 0001193125-17-355847 Size: 174 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ D - Notice of Exempt Offering of Securities Filed: 2017-11-20 AccNo: 0001461993-17-000005 Size: 15 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1] Filed: 2017-11-16 AccNo: 0001193125-17-345560 Size: 106 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-13 AccNo: 0001193125-17-341095 Size: 337 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2017-11-13 AccNo: 0001193125-17-340988 Size: 88 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-11-09 AccNo: 0001193125-17-338816 Size: 21 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接